---
title: "Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 8-K: FY2025 Q2 EPS: USD 1.58"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/248944609.md"
datetime: "2025-07-17T10:04:17.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/248944609.md)
  - [en](https://longbridge.com/en/news/248944609.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/248944609.md)
generator: "portal-rs"
---

# Texas Capital Bancshrs Pref Share TCBIO 5.75 Perp 06/15/26 B | 8-K: FY2025 Q2 EPS: USD 1.58

EPS: As of FY2025 Q2, the actual value is USD 1.58.

EBIT: As of FY2025 Q2, the actual value is USD 102.19 K.

### Segment Revenue

-   **Total Revenue**: $307.5 million in Q2 2025, compared to $267.0 million in Q2 2024, showing an increase driven by improved capital markets and sales and trading fees.

### Operational Metrics

-   **Net Income**: $77.3 million in Q2 2025, up from $42.0 million in Q2 2024.
-   **Return on Average Assets**: 0.99% in Q2 2025, compared to 0.57% in Q2 2024.
-   **Efficiency Ratio**: 61.9% in Q2 2025, compared to 70.4% in Q2 2024, indicating improved operational efficiency.

### Cash Flow

-   **Net Interest Income**: Increased to $253.4 million in Q2 2025 from $216.6 million in Q2 2024, supported by continued LHI growth and reduced funding costs.

### Unique Metrics

-   **Treasury Product Fees**: Increased to $11.6 million, marking the fourth consecutive record quarter.
-   **Assets Under Management**: Increased 8% quarter-over-quarter to $4.1 billion, driven by accelerated client adoption of the improved platform.

### Outlook / Guidance

-   Texas Capital Bancshares, Inc. anticipates delivering durable, through-cycle results for both clients and shareholders, supported by the strength of its balance sheet and breadth of capabilities as it enters the second half of the year.
-   The company expects low double-digit percentage growth in total revenue for the full year 2025, with a mid to high single-digit percentage growth in non-interest expense.
-   The CET1 ratio target remains unchanged, and the tax rate is expected to be approximately 25% for the full year 2025. The company aims to achieve a quarterly return on average assets of 1.10% in the second half of 2025.

### Related Stocks

- [TCBIO.US](https://longbridge.com/en/quote/TCBIO.US.md)

## Related News & Research

- [Oil set for second weekly rise as unsettled US-Iran war crimps supply](https://longbridge.com/en/news/296555193.md)
- [IREN Just Passed Its Biggest AI Test as Microsoft and Nvidia Bet Billions](https://longbridge.com/en/news/296533962.md)
- [Google Is Reportedly Working with AMD for Its New TPU. What This Means for AMD Stock.](https://longbridge.com/en/news/296528134.md)
- [Trump Boosted INTC and DELL: Now He Says ‘Do Magnets’—Are MP and USAR Stocks Next?](https://longbridge.com/en/news/296591886.md)
- [Why Iovance Biotherapeutics Stock Hit 52-Week High](https://longbridge.com/en/news/296522969.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**